NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

ImmunityBio Inc (NASDAQ: IBRX)

 
IBRX Technical Analysis
5
As on 22nd Apr 2025 IBRX STOCK Price closed @ 2.69 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.99 & Strong Sell for SHORT-TERM with Stoploss of 3.99 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

IBRXSTOCK Price

Open 2.54 Change Price %
High 2.75 1 Day 0.18 7.17
Low 2.54 1 Week 0.23 9.35
Close 2.69 1 Month -0.22 -7.56
Volume 6167048 1 Year -1.01 -27.30
52 Week High 9.15 | 52 Week Low 2.32
 
NASDAQ USA Most Active Stocks
AMRS 0.14 100.00%
NVDA 98.89 2.04%
WNW 2.45 97.58%
LMDX 0.02 0.00%
TSLA 237.97 4.60%
SXTC 2.08 103.92%
PLUG 0.87 10.13%
AKTS 0.04 0.00%
INTC 19.51 3.56%
LILM 0.05 0.00%
 
NASDAQ USA Top Gainers Stocks
KTRA 6.30 2763.64%
MCRB 8.16 2105.41%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
ZVZZT 69.19 464.82%
NDRAW 0.03 200.00%
WINVR 0.12 140.00%
GLSPT 33.43 138.62%
BIOC 0.07 133.33%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
AXAS 0.03 -70.00%
BPTH 0.21 -66.67%
TFFP 0.06 -62.50%
MILEW 0.06 -53.85%
LOTZW 0.01 -50.00%
BTAQW 0.01 -50.00%
 
 
IBRX
Daily Charts
IBRX
Intraday Charts
Whats New @
Bazaartrend
IBRX
Free Analysis
 
IBRX Important Levels Intraday
RESISTANCE3.09
RESISTANCE2.96
RESISTANCE2.88
RESISTANCE2.80
SUPPORT2.58
SUPPORT2.50
SUPPORT2.42
SUPPORT2.29
 
IBRX Forecast April 2025
4th UP Forecast6.89
3rd UP Forecast5.54
2nd UP Forecast4.71
1st UP Forecast3.88
1st DOWN Forecast1.5
2nd DOWN Forecast0.67
3rd DOWN Forecast-0.16
4th DOWN Forecast-1.51
 
IBRX Weekly Forecast
4th UP Forecast4.93
3rd UP Forecast4.21
2nd UP Forecast3.77
1st UP Forecast3.32
1st DOWN Forecast2.06
2nd DOWN Forecast1.61
3rd DOWN Forecast1.17
4th DOWN Forecast0.45
 
IBRX Forecast2025
4th UP Forecast18.59
3rd UP Forecast13.49
2nd UP Forecast10.34
1st UP Forecast7.19
1st DOWN Forecast-1.81
2nd DOWN Forecast-4.96
3rd DOWN Forecast-8.11
4th DOWN Forecast-13.21
 
 
IBRX Other Details
Segment EQ
Market Capital 3133167616.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
IBRX Address
IBRX
 
IBRX Latest News
 
Your Comments and Response on ImmunityBio Inc
 
IBRX Business Profile
ImmunityBio, Inc., a clinical-stage immunotherapy company, develops cell and immune therapies to treat cancers and infectious diseases. The company develops Anktiva (N-803), an IL-15 superagonist and PD-L1 that activates natural killer and T effector cells in combination with chemo and trodelvy to treat cancers, such as merkel cell carcinoma, advanced pancreatic cancer, and advanced triple negative breast cancer; and an albumin-linked formulation of doxorubicin (Aldoxorubicin) to treat breast cancer, hodgkin lymphoma, SCLC, sarcoma, and glioblastoma. It also develops a memory T-cell cancer vaccine to deliver tumor-associated antigens and neoepitopes; and a human adenovirus 5 COVID-19 vaccine. The company was founded in 2014 and is based in San Diego, California. Address: 3530 John Hopkins Court, San Diego, CA, United States, 92121
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service